The four or more medicines (FOMM) support service: results from an evaluation of a new community pharmacy service aimed at over-65s

International Journal of Pharmacy Practice

Volumn , Issue , 2015, Pages 407-414

  Twigg, Michael J ^a   Wright, David ^a   Barton, Garry R ^b   Thornley, Tracey ^c   Kerr, Clare ^d  

^a School of Pharmacy   (United Kingdom)

^b UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^c The Boots Company PLC   (United Kingdom)

^d External Affairs Celesio UK   (United Kingdom)

Author keywords

adherence; community pharmacy; falls; polypharmacy; quality of life

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; NARCOTIC ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

AGED; ARTICLE; CHRONIC PAIN; COST EFFECTIVENESS ANALYSIS; FALLING; FEMALE; FOLLOW UP; HEALTH CARE COST; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; PHARMACEUTICAL CARE; PHARMACIST; PHARMACY; POTENTIALLY INAPPROPRIATE MEDICATION; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; RISK REDUCTION;

EID: 84984657048     PISSN: 09617671     EISSN: 20427174     Source Type: Journal    
DOI: 10.1111/ijpp.12196     Document Type: Article

References (40)

1. Department of Health. Choosing Health Through Pharmacy – A Programme for Pharmaceutical Public Health 2005–2015. London: The Stationery Office, 2005.
2. Rollason V, Vogt N. Reduction of polypharmacy in the elderly: a systematic review of the role of the pharmacist. Drugs Aging 2003; 20: 817–832.
3. Payne RA et al. Is polypharmacy always hazardous? A retrospective cohort analysis using linked electronic health records from primary and secondary care. Br J Clin Pharmacol 2014; 77: 1073–1082.
4. Parsons C et al. Potentially inappropriate prescribing in older people with dementia in care homes. Drugs Aging 2012; 29: 143–155.
5. WHO. Adherence to Long-Term Therapies. Evidence for Action. Geneva: World Health Organisation, 2003.
6. Department of Health. Pharmacy in England: Building on Strengths – Delivering the Future. London: The Stationery Office, 2008.
7. Bond C et al. Repeat prescribing: a role for community pharmacists in controlling and monitoring repeat prescriptions. Br J Gen Pract 2000; 50: 271–275.
8. Chumney E, Robinson L. The effects of pharmacist interventions on patients with polypharmacy. Pharm Pract 2006; 4: 103–109.
9. Kaur S et al. Interventions that can reduce inappropriate prescribing in the elderly: a systematic review. Drugs Aging 2009; 26: 1013–1028.
10. Patterson SM et al. Interventions to improve the appropriate use of polypharmacy for older people (Review). Cochrane Database Syst Rev 2012; (5): CD008165.
11. PSNC. PSNC Contract Workbook. Pharmaceutical Services Negotiating Committee ed. London: PSNC, 2009.
12. Elliott RA et al. Cost-effectiveness of adherence-enhancing interventions: a quality assessment of the evidence. Ann Pharmacother 2005; 39: 508–515.
13. Haynes RB et al. Interventions for enhancing medication adherence. Cochrane Database Syst Rev 2008; (2): CD000011.
14. Easthall C et al. A meta-analysis of cognitive-based behaviour change techniques as interventions to improve medication adherence. BMJ Open 2013; 3: e002749.
15. O'Mahony D et al. STOPP & START criteria: a new approach to detecting potentially inappropriate prescribing in old age. Eur Geriatr Med 2010; 1: 45–51.
16. Beers MH et al. Explicit criteria for determining inappropriate medication use in nursing home residents. Arch Intern Med 1991; 151: 1825–1832.
17. NICE. Falls: Assessment and Prevention of Falls in Older People. N.I.f.H.a.C. Excellence ed. London: The Stationery Office, 2013.
18. van der Velde N et al. Risk of falls after withdrawal of fall-risk-increasing drugs: a prospective cohort study. Br J Clin Pharmacol 2006; 63: 232–237.
19. Cooper JW, Burfield AH. Medication interventions for fall prevention in the older adult. J Am Pharm Assoc (2003) 2009; 49: e70–e82. quiz e83-4.
20. Gagliese L, Melzack R. Chronic pain in elderly people. Pain 1997; 70: 3–14.
21. Department of Health. National Service Framework for Older People. London: The Stationary Office, 2001.
22. Katz N. The impact of pain management on quality of life. J Pain Symptom Manage 2002; 24(1 Suppl. 1): S38–S47.
23. HSCIC. Prescription Cost Analysis. Health & Social Care Information Centre ed. London: National Statistics, 2013.
24. Morisky DE et al. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens 2008; 10: 348–354.
25. Herdman M et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res 2011; 20: 1727–1736.
26. van Hout B et al. Interim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value sets. Value Health 2012; 15: 708–715.
27. Curtis L. Unit Costs of Health and Social Care 2012. Canterbury: Personal Social Services Research Unit: The University of Kent, 2012.
28. Department of Health. Reference Costs 2011–2012. London: Department of Health, 2012.
29. Noble SM et al. Missing data in trial-based cost-effectiveness analysis: the current state of play. Health Econ 2012; 21: 187–200.
30. Manca A et al. Estimating mean QALYs in trial-based cost-effectiveness analysis: the importance of controlling for baseline utility. Health Econ 2005; 14: 487–496.
31. NICE. Guide to the Methods of Technology Appraisal 2013. London: National Institute of Health and Clinical Excellence (NICE) publications, 2013.
32. Fenwick E et al. Cost-effectiveness acceptability curves-facts, fallacies and frequently asked questions. Health Econ 2004; 13: 405–415.
33. Matsuyama JR et al. Pharmacists' interventions using an electronic medication-event monitoring device's adherence data versus pill counts. Ann Pharmacother 1993; 27: 851–855.
34. Zermansky AG et al. Clinical medication review by a pharmacist of elderly people living in care homes – Randomised controlled trial. Age Ageing 2006; 35: 586–591.
35. Twigg M et al. The current and future roles of community pharmacists: views and experiences of patients with type 2 diabetes. Res Soc Admin Pharm 2012; 9: 777–789.
36. Gellad WF et al. A systematic review of barriers to medication adherence in the elderly: looking beyond cost and regimen complexity. Am J Geriatr Pharmacother 2011; 9: 11–23.
37. Simpson SH et al. A meta-analysis of the association between adherence to drug therapy and mortality. BMJ 2006; 333: 15.
38. Payne RA, Avery AJ. Polypharmacy: one of the greatest prescribing challenges in general practice. Br J Gen Pract 2011; 61: 83–84.
39. Duerden M et al. Polypharmacy and Medicines Optimisation: Making it Safe and Sound. London: The King's Fund, 2013.
40. NICE. Consultation on Potential New Indicators for the 2015/16 Quality and Outcomes Framework (QOF). London: National Institute for Health and Care Excellence, 2013.